Cargando…

Update on the therapeutic significance of estrogen receptor beta in malignant gliomas

Malignant glioma is the most fatal of the astrocytic lineage tumors despite therapeutic advances. Men have a higher glioma incidence than women, indicating that estrogen level differences between men and women may influence glioma pathogenesis. However, the mechanism underlying the anticancer effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Yu-Long, Zou, Shuang, Wang, Xun, Lou, Jia-Cheng, Xing, Jin-Shan, Yu, Min, Zhang, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655319/ https://www.ncbi.nlm.nih.gov/pubmed/29113424 http://dx.doi.org/10.18632/oncotarget.20970

Ejemplares similares

The potential roles of aquaporin 4 in malignant gliomas
por: Lan, Yu-Long, et al.
Publicado: (2017)

Marinobufagenin inhibits glioma growth through sodium pump α1 subunit and ERK signaling‐mediated mitochondrial apoptotic pathway
por: Lan, Yu‐Long, et al.
Publicado: (2018)

Anti-cancer effects of dopamine in human glioma: involvement of mitochondrial apoptotic and anti-inflammatory pathways
por: Lan, Yu-Long, et al.
Publicado: (2017)

Expression and therapeutic significance of estrogen receptor β in malignant pleural mesothelioma
por: Pinton, Giulia, et al.
Publicado: (2017)

Treating malignant glioma in Chinese patients: update on temozolomide
por: Chang, Liang, et al.
Publicado: (2014)

Gamabufotalin induces a negative feedback loop connecting ATP1A3 expression and the AQP4 pathway to promote temozolomide sensitivity in glioblastoma cells by targeting the amino acid Thr794
por: Lan, Yu‐Long, et al.
Publicado: (2019)

Update on the synergistic effect of HSL and insulin in the treatment of metabolic disorders
por: Lan, Yu-Long, et al.
Publicado: (2019)

Identification of the prognostic and immunological roles of aquaporin 4: A potential target for survival and immunotherapy in glioma patients
por: Lan, Yu-Long, et al.
Publicado: (2022)

Migration/Invasion of Malignant Gliomas and Implications for Therapeutic Treatment
por: Liu, Ching-Ann, et al.
Publicado: (2018)

Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist
por: He, Yi, et al.
Publicado: (2022)

New therapeutic approaches for malignant glioma: in search of the Rosetta stone
por: Auffinger, Brenda, et al.
Publicado: (2012)

Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer
por: Liu, Jinyou, et al.
Publicado: (2017)

S32. ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS POTENTIAL THERAPEUTICS FOR SCHIZOPHRENIA?
por: Breier, Alan, et al.
Publicado: (2020)

Convection-enhanced Delivery of Therapeutics for Malignant Gliomas
por: SAITO, Ryuta, et al.
Publicado: (2017)

Potential Therapeutic Effects of Thiazolidinedione on Malignant Glioma
por: Sheu, Meei-Ling, et al.
Publicado: (2022)

The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway
por: Chen, Chih-Wei, et al.
Publicado: (2021)

The Clinical Significance of Ependymal Enhancement at Presentation in Patients with Malignant Glioma
por: Kaidar-Person, Orit, et al.
Publicado: (2015)

Estrogen receptor beta treats Alzheimer's disease
por: Tian, Zhu, et al.
Publicado: (2013)

The prevalence and prognostic significance of estrogen receptor beta expression in non-small cell lung cancer
por: Enwere, Emeka K., et al.
Publicado: (2020)

Artemether Combined with shRNA Interference of Vascular Cell Adhesion Molecule-1 Significantly Inhibited the Malignant Biological Behavior of Human Glioma Cells
por: Wang, Ying-Bin, et al.
Publicado: (2013)

Combined Estrogen Alpha and Beta Receptor Expression Has a Prognostic Significance for Colorectal Cancer Patients
por: Topi, Geriolda, et al.
Publicado: (2022)

Estrogen rescues heart failure through estrogen receptor Beta activation
por: Iorga, Andrea, et al.
Publicado: (2018)

AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells
por: Shao, Ying-Ying, et al.
Publicado: (2017)

Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma
por: Blobner, Jens, et al.
Publicado: (2023)

Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas
por: Wu, Xing, et al.
Publicado: (2016)

The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors
por: Gu, Yu, et al.
Publicado: (2014)

Advanced MR Imaging of Gliomas: An Update
por: Kao, Hung-Wen, et al.
Publicado: (2013)

Estrogen receptor β: an overview and update
por: Zhao, Chunyan, et al.
Publicado: (2008)

An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma
por: Davis, Alexander, et al.
Publicado: (2022)

Erratum to: Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas
por: Wu, Xing, et al.
Publicado: (2016)

Malignant and Non-malignant Uterine and Vaginal Lesions in Mice Receiving Estrogens and Estrogens and Androgens Simultaneously
por: Gardner, W. U., et al.
Publicado: (1939)

GLIOMA-06 THE GLIOMA CONNECTOME PROJECT – UPDATE
por: Brem, Steven
Publicado: (2023)

Expression, prognostic significance and therapeutic implications of PD‐L1 in gliomas
por: Vimalathas, Gayaththri, et al.
Publicado: (2021)

Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity
por: Pinton, Giulia, et al.
Publicado: (2014)

Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells
por: Manente, Arcangela G., et al.
Publicado: (2015)

Estrogen receptor beta expression in prostate adenocarcinoma
por: Asgari, Mojgan, et al.
Publicado: (2011)

The role of estrogen receptor beta in breast cancer
por: Zhou, Yujing, et al.
Publicado: (2020)

Targeting immune checkpoints in malignant glioma
por: Zhang, Xuhao, et al.
Publicado: (2016)

G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer
por: Xu, Shen, et al.
Publicado: (2019)

Advances in the intraoperative delineation of malignant glioma margin
por: Jiang, Shan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5j8tpdv2fvnrm0e8ihh0nrc1la